Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
Aventiv Research
817
mi
from
Columbus, OH
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Aventiv Research
817
mi
from
Columbus, OH
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
Digestive Disease Associates, Ltd.
1183
mi
from
Wyomissing, PA
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Digestive Disease Associates, Ltd.
1183
mi
from
Wyomissing, PA
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
Rapid City Medical Center, LLP
520
mi
from
Rapid City, SD
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Rapid City Medical Center, LLP
520
mi
from
Rapid City, SD
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
Advanced Gastroenterology
492
mi
from
Union City, TN
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Advanced Gastroenterology
492
mi
from
Union City, TN
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
DHAT Research Institute
334
mi
from
Richardson, TX
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
DHAT Research Institute
334
mi
from
Richardson, TX
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
Advanced Research Institute
789
mi
from
Ogden, UT
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Advanced Research Institute
789
mi
from
Ogden, UT
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
Care Access Research
777
mi
from
Salt Lake City, UT
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Care Access Research
777
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
Univ of Pennsylvania
1223
mi
from
Philadelphia, PA
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Univ of Pennsylvania
1223
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
Del Sol Research Management, LLC
828
mi
from
Chandler, AZ
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Del Sol Research Management, LLC
828
mi
from
Chandler, AZ
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
Del Sol Research Management
828
mi
from
Tucson, AZ
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Del Sol Research Management
828
mi
from
Tucson, AZ
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
Western Connecticut Health Network
1317
mi
from
Danbury, CT
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Western Connecticut Health Network
1317
mi
from
Danbury, CT
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
Clinical Trials of America, Inc.
973
mi
from
West Monroe, LA
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Clinical Trials of America, Inc.
973
mi
from
West Monroe, LA
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
Henry Ford Medical Center
826
mi
from
Novi, MI
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Henry Ford Medical Center
826
mi
from
Novi, MI
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
St Louis Center For Clinical Research
407
mi
from
Saint Louis, MO
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
St Louis Center For Clinical Research
407
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
Unity Clinical Research
158
mi
from
Oklahoma City, OK
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Unity Clinical Research
158
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
Avant Research Associates, LLC - Austin
519
mi
from
Austin, TX
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Avant Research Associates, LLC - Austin
519
mi
from
Austin, TX
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
Avant Research Associates
570
mi
from
Beaumont, TX
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Avant Research Associates
570
mi
from
Beaumont, TX
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
Verity Research
1112
mi
from
Fairfax, VA
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Verity Research
1112
mi
from
Fairfax, VA
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
AZ Sint-Lucas
mi
from
Brugge,
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
AZ Sint-Lucas
mi
from
Brugge,
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
Sc Clinical Research, Inc.
1158
mi
from
Garden Grove, CA
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Sc Clinical Research, Inc.
1158
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
Focilmed
1216
mi
from
Oxnard, CA
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Focilmed
1216
mi
from
Oxnard, CA
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
St. Jude Healthcare
mi
from
Yorba Linda, CA
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
St. Jude Healthcare
mi
from
Yorba Linda, CA
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
Eastern Research, Inc.
1314
mi
from
Hialeah, FL
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Eastern Research, Inc.
1314
mi
from
Hialeah, FL
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
DBC Research, Corp
1309
mi
from
Pembroke Pines, FL
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
DBC Research, Corp
1309
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
Northwestern Medical Faculty Foundation
611
mi
from
Chicago, IL
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Northwestern Medical Faculty Foundation
611
mi
from
Chicago, IL
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
MediSphere Medical Research Center, an AMR affiliate
559
mi
from
Evansville, IN
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
MediSphere Medical Research Center, an AMR affiliate
559
mi
from
Evansville, IN
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
Gastroenterology Associates
mi
from
Hazard, KY
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Gastroenterology Associates
mi
from
Hazard, KY
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
Long Island Gastrointestinal Research Group, LLP
1301
mi
from
Great Neck, NY
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Long Island Gastrointestinal Research Group, LLP
1301
mi
from
Great Neck, NY
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
Weill-Cornell Medical College
1289
mi
from
New York, NY
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Weill-Cornell Medical College
1289
mi
from
New York, NY
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
Bernstein Clinical Research Center
724
mi
from
Cincinnati, OH
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Bernstein Clinical Research Center
724
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
Allergy and Asthma Center of South Oregon
mi
from
Medford, OR
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
Allergy and Asthma Center of South Oregon
mi
from
Medford, OR
Click here to add this to my saved trials
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated:  12/31/1969
University of Utah
777
mi
from
Salt Lake City, UT
Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)
FLUTicasone in Eosinophilic Esophagitis (FLUTE): A Randomized, Double-blind, Placebo-controlled, Dose-ranging, and Maintenance Study of APT-1011 in Subjects With Eosinophilic Esophagitis
Status: Enrolling
Updated: 12/31/1969
University of Utah
777
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Study of PF-05221304 in Subjects With Varying Degrees of Hepatic Impairment
A Phase 1, Non-randomized, Open-label, Single-dose, Parallel Cohort Study To Compare The Pharmacokinetics Of Pf-05221304 In Adult Subjects With Varying Degrees Of Hepatic Impairment Relative To Subjects Without Hepatic Impairment
Status: Enrolling
Updated:  12/31/1969
Pfizer Clinical Research Unit
4719
mi
from
Brussels,
Study of PF-05221304 in Subjects With Varying Degrees of Hepatic Impairment
A Phase 1, Non-randomized, Open-label, Single-dose, Parallel Cohort Study To Compare The Pharmacokinetics Of Pf-05221304 In Adult Subjects With Varying Degrees Of Hepatic Impairment Relative To Subjects Without Hepatic Impairment
Status: Enrolling
Updated: 12/31/1969
Pfizer Clinical Research Unit
4719
mi
from
Brussels,
Click here to add this to my saved trials
Study of PF-05221304 in Subjects With Varying Degrees of Hepatic Impairment
A Phase 1, Non-randomized, Open-label, Single-dose, Parallel Cohort Study To Compare The Pharmacokinetics Of Pf-05221304 In Adult Subjects With Varying Degrees Of Hepatic Impairment Relative To Subjects Without Hepatic Impairment
Status: Enrolling
Updated:  12/31/1969
Orlando Clinical Research Center
1144
mi
from
Orlando, FL
Study of PF-05221304 in Subjects With Varying Degrees of Hepatic Impairment
A Phase 1, Non-randomized, Open-label, Single-dose, Parallel Cohort Study To Compare The Pharmacokinetics Of Pf-05221304 In Adult Subjects With Varying Degrees Of Hepatic Impairment Relative To Subjects Without Hepatic Impairment
Status: Enrolling
Updated: 12/31/1969
Orlando Clinical Research Center
1144
mi
from
Orlando, FL
Click here to add this to my saved trials
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated:  12/31/1969
Boyett Health Services
603
mi
from
Hamilton, AL
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated: 12/31/1969
Boyett Health Services
603
mi
from
Hamilton, AL
Click here to add this to my saved trials
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated:  12/31/1969
Woodland International Research Group, Inc.
372
mi
from
Little Rock, AR
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated: 12/31/1969
Woodland International Research Group, Inc.
372
mi
from
Little Rock, AR
Click here to add this to my saved trials
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated:  12/31/1969
Collaborative Neuroscience Network, Inc.
1171
mi
from
Long Beach, CA
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated: 12/31/1969
Collaborative Neuroscience Network, Inc.
1171
mi
from
Long Beach, CA
Click here to add this to my saved trials
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated:  12/31/1969
Pacific Research Partners, LLC
1331
mi
from
Oakland, CA
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated: 12/31/1969
Pacific Research Partners, LLC
1331
mi
from
Oakland, CA
Click here to add this to my saved trials
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated:  12/31/1969
Sarkis Clinical Trials
1046
mi
from
Gainesville, FL
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated: 12/31/1969
Sarkis Clinical Trials
1046
mi
from
Gainesville, FL
Click here to add this to my saved trials
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated:  12/31/1969
Amit Vijapura
1055
mi
from
Jacksonville, FL
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated: 12/31/1969
Amit Vijapura
1055
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated:  12/31/1969
Meridien Research
1135
mi
from
Lakeland, FL
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated: 12/31/1969
Meridien Research
1135
mi
from
Lakeland, FL
Click here to add this to my saved trials
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated:  12/31/1969
Innovative Clinical Research, Inc
1300
mi
from
Lauderhill, FL
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated: 12/31/1969
Innovative Clinical Research, Inc
1300
mi
from
Lauderhill, FL
Click here to add this to my saved trials
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated:  12/31/1969
Scientific Clinical Research
1316
mi
from
North Miami, FL
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated: 12/31/1969
Scientific Clinical Research
1316
mi
from
North Miami, FL
Click here to add this to my saved trials
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated:  12/31/1969
Phoenix Medical Research
192
mi
from
Prairie Village, KA
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated: 12/31/1969
Phoenix Medical Research
192
mi
from
Prairie Village, KA
Click here to add this to my saved trials
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated:  12/31/1969
Louisiana Research Associates, Inc.
700
mi
from
New Orleans, LA
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated: 12/31/1969
Louisiana Research Associates, Inc.
700
mi
from
New Orleans, LA
Click here to add this to my saved trials
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated:  12/31/1969
Louisiana Clinical Research
441
mi
from
Shreveport, LA
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated: 12/31/1969
Louisiana Clinical Research
441
mi
from
Shreveport, LA
Click here to add this to my saved trials
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated:  12/31/1969
Stanley Street Treatment and Resources
1439
mi
from
Fall River, MA
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated: 12/31/1969
Stanley Street Treatment and Resources
1439
mi
from
Fall River, MA
Click here to add this to my saved trials
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated:  12/31/1969
Adams Clinical Trials LLC
1437
mi
from
Watertown, MA
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated: 12/31/1969
Adams Clinical Trials LLC
1437
mi
from
Watertown, MA
Click here to add this to my saved trials
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated:  12/31/1969
Precise Research Centers
563
mi
from
Flowood, MS
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated: 12/31/1969
Precise Research Centers
563
mi
from
Flowood, MS
Click here to add this to my saved trials
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated:  12/31/1969
St. Louis Clinical Trials, LLC
403
mi
from
Saint Louis, MO
Open-Label Treatment Extension Study
An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder
Status: Enrolling
Updated: 12/31/1969
St. Louis Clinical Trials, LLC
403
mi
from
Saint Louis, MO
Click here to add this to my saved trials